Christine Russell
Nurse Practitioner · Warren, MINPI 1932742087
Payments from drug & device makers
Across 168 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$560
- AstraZeneca$443
- Novartis$381
- Amgen$337
- Esperion Therapeutics, Inc.$262
- Boehringer Ingelheim$191
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,37197%
- Education$903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 29 | $560 |
| AstraZeneca | 18 | $443 |
| Novartis | 19 | $381 |
| Amgen | 20 | $337 |
| Esperion Therapeutics, Inc. | 14 | $262 |
| Boehringer Ingelheim | 12 | $191 |
| Pfizer | 9 | $183 |
| Medtronic | 4 | $170 |
| Boston Scientific | 4 | $146 |
| Lexicon Pharmaceuticals, Inc. | 6 | $115 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $62 |
| Sanofi-aventis U.S. LLC | 3 | $57 |
| Johnson & Johnson | 3 | $55 |
| Abbott | 2 | $47 |
| Edwards Lifesciences | 2 | $45 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $44 |
| Scpharmaceuticals Inc. | 2 | $39 |
| Viatris Specialty LLC | 1 | $35 |
| Bayer | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| GSK | 1 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $26 |
| Shockwave Medical, Inc | 1 | $25 |
| Novo Nordisk | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Heartflow, Inc. | 1 | $20 |
| Sanofi | 1 | $18 |
| Irhythm Technologies, Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Verona Pharma, Inc. | 1 | $15 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $10 |
How this compares
$3,461 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 54 | $65,094 |
| EntrestoSacubitril/Valsartan | 16 | $30,211 |
| Ezetimibe | 50 | $1,153 |
| Ranolazine ErRanolazine | 12 | $1,132 |
| Rosuvastatin Calcium | 69 | $1,042 |
| Metoprolol Succinate | 58 | $1,033 |
| Telmisartan | 18 | $943 |
| Losartan Potassium | 65 | $720 |
| Atorvastatin Calcium | 40 | $645 |
| Metoprolol Tartrate | 43 | $474 |
| Amlodipine Besylate | 71 | $469 |
| Carvedilol | 23 | $276 |
| Lisinopril | 30 | $210 |
| Furosemide | 40 | $201 |
| Potassium Chloride | 14 | $175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $183 | $65,09454 claims |
| NovartisEntresto | $381 | $30,21116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Warren
- Jennifer MeitznerWarren$13K
- Leigh Anne SchermanWarren$8K
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Elizabeth KirshnerAnn Arbor$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.